Evidence map›Paper›PMID 39838305›Full record

ReviewMolecular medicine (Cambridge, Mass.)2025

Endocrine and metabolic alterations in response to systemic inflammation and sepsis: a review article.

Syed Faizan Mehdi, Muhammad Hamza Qureshi, Salman Pervaiz, Karishma Kumari, Edwin Saji, Mahnoor Shah, Ahmad Abdullah, Kamran Zahoor, Hafiza Amna Qadeer, Disha Kumari Katari and 6 more

Abstract readReview
In one paragraph

Review in Molecular medicine (Cambridge, Mass.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Temporal Metabolomics Profiling Reveals Liver Metabolic Control in Single and Repeated Exhaustive Exercise in Murine Models.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Syed Faizan MehdiThe Feinstein Institutes for Medical Research/Northwell Health, Manhasset, NY, USA.
Muhammad Hamza QureshiThe Feinstein Institutes for Medical Research/Northwell Health, Manhasset, NY, USA.
Salman PervaizThe Feinstein Institutes for Medical Research/Northwell Health, Manhasset, NY, USA.
Karishma KumariThe Feinstein Institutes for Medical Research/Northwell Health, Manhasset, NY, USA.
Edwin SajiThe Feinstein Institutes for Medical Research/Northwell Health, Manhasset, NY, USA.
Mahnoor ShahThe Feinstein Institutes for Medical Research/Northwell Health, Manhasset, NY, USA.
Ahmad AbdullahThe Feinstein Institutes for Medical Research/Northwell Health, Manhasset, NY, USA.
Kamran ZahoorThe Feinstein Institutes for Medical Research/Northwell Health, Manhasset, NY, USA.
Hafiza Amna QadeerThe Feinstein Institutes for Medical Research/Northwell Health, Manhasset, NY, USA.
Disha Kumari KatariThe Feinstein Institutes for Medical Research/Northwell Health, Manhasset, NY, USA.
Christine MetzThe Feinstein Institutes for Medical Research/Northwell Health, Manhasset, NY, USA.
Lopa MishraThe Feinstein Institutes for Medical Research/Northwell Health, Manhasset, NY, USA.
Derek LeRoithDivision of Endocrinology, Diabetes & Bone Disease, Icahn School of Medicine at Mt. Sinai, New York, NY, USA.
Kevin TraceyThe Feinstein Institutes for Medical Research/Northwell Health, Manhasset, NY, USA.
Michael J BrownsteinAzevan Pharmaceuticals Inc., Bethlehem, PA, USA.
Jesse RothThe Feinstein Institutes for Medical Research/Northwell Health, Manhasset, NY, USA. jroth2@northwell.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Severe sepsis is cognate with life threatening multi-organ dysfunction. There is a disturbance in endocrine functions with alterations in several hormonal pathways. It has frequently been linked with dysfunction in the hypothalamic pituitary-adrenal axis (HPA). Increased cortisol or cortisolemia is evident throughout the acute phase, along with changes in the hypothalamic pituitary thyroid (HPT) axis, growth hormone-IGF-1 axis, insulin-glucose axis, leptin, catecholamines, renin angiotensin aldosterone axis, ghrelin, glucagon, hypothalamic pituitary gonadal (HGA) axis, and fibroblast growth factor-21. These changes and metabolic alterations constitute the overall response to infection in sepsis. Further research is essential to look into the hormonal changes that occur during sepsis, not only to understand their potential relevance in therapy but also because they may serve as prognostic indicators.

Indexed as

Endocrine SystemInflammationSepsisAnimalsHormonesHumansHypothalamo-Hypophyseal SystemPituitary-Adrenal SystemHormonesEndocrineHormonesInflammationMetabolismSepsisSeptic shock

Identifiers

PMID39838305
PMCPMC11752782

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.